No results found for “”
No results found for filter “”
-
Statements & press releases 24.07.24
EFPIA position on EHDS
The EHDS will require the public and private sectors to work together in new and innovative ways. We look forward to working with the EU institutions and...
Read Article -
Blog articles 24.07.24
Data Sharing Playbook can unlock health partnerships
Health research collaborations mean sharing data – we can deliver faster if we identify and remove obstacles early, write IHI's Niklas Blomberg and EFPIA's...
Read Article -
Statements & press releases 18.07.24
EFPIA Response to the publication of Political Guidelines for the Next European Commission 2024-2029
The dedicated life sciences strategy is an important part of the wider drive to boost European competitiveness over the next five years.
Read Article -
EFPIA News 11.07.24
NIRO: Navigating innovation and research opportunities
A new tool to help navigate the complex world of health R&I funding programmes.
Read Article -
EFPIA News 08.07.24
Breaking down barriers: Making cross-border access to clinical trials a reality
Collaborative effort by EFGCP and EFPIA develops action plan to address participation barriers in Europe
Read Article -
Statements & press releases 04.07.24
Joint Statement for an Ambitious FP10
Investing in Europe’s Future Competitiveness through Collaborative Research, Development, and Innovation
Read Article -
Blog articles 04.07.24
Cardiovascular health: urgent action needed on EU’s #1 killer
Innovation and competitiveness must be at the heart of Council Conclusions on cardiovascular health
Read Article -
Statements & press releases 28.06.24
Strategic Agenda 2024-2029: an opportunity to close the gap with other regions of the world
As we begin a new EU mandate, the focus on competitiveness of the Strategic Agenda gives us an opportunity to restore Europe’s leadership in life sciences....
Read Article -
Statements & press releases 24.06.24
European pharmaceutical industry calls for Competitiveness Strategy and dedicated Office for European...
"Regaining Europe’s position as a world-leader in medical science requires strategic and dedicated focus at EU level" said Nathalie Moll.
Read Article -
EFPIA News 12.06.24
New data from EFPIA reveals multiple factors leading to unequal access to medicines for patients across...
"Whatever the reason, whatever the cause, we stand ready to play our part in reducing the time it takes for patients to access the medicines we discover,...
Read Article -
Statements & press releases 10.06.24
Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement ...
We are leading the transition towards the decarbonisation in the pharmaceutical sector by setting ambitious science-based targets, investing in renewable...
Read Article -
Statements & press releases 05.06.24
Keep health front and centre in the EU elections and beyond – a call from the Patient Think Tank
The Patient Think Tank (PTT) is a forum for dialogue between the European research-based pharmaceutical industry and patient organisations, created and...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 11.07.24
NIRO: Navigating innovation and research opportunities
A new tool to help navigate the complex world of health R&I funding programmes.
Read Article -
EFPIA News 08.07.24
Breaking down barriers: Making cross-border access to clinical trials a reality
Collaborative effort by EFGCP and EFPIA develops action plan to address participation barriers in Europe
Read Article -
EFPIA News 12.06.24
New data from EFPIA reveals multiple factors leading to unequal access to medicines for patients across...
"Whatever the reason, whatever the cause, we stand ready to play our part in reducing the time it takes for patients to access the medicines we discover,...
Read Article -
EFPIA News 04.06.24
Insights from EFPIA's Reliance Webinar
On the 19th of March EFPIA have hosted a joint industry webinar on Reliance, providing a platform for information and discussion on use of EMA assessment...
Read Article -
EFPIA News 26.04.24
Journal article - Evolving assessment pathways for precision oncology medicines to improve patient access:...
This study describes challenges in assessing PO and TA medicines, explores possible solutions, and provides actionable recommendations to facilitate an...
Read Article -
EFPIA News 26.04.24
White paper on circular economy
Continued adoption of circular economy principles into the pharmaceutical sector can reduce materials extraction and operational waste, contribute to a...
Read Article -
EFPIA News 28.03.24
NIRO: Navigating Innovation & Research Opportunities
NIRO helps you find available European and international funds for research & innovation.
Read Article -
EFPIA News 13.02.24
European business calls for deepening the EU Single Market and renewing the dynamic of European integration...
Read the joint statement from 26 trade associations.
Read Article -
EFPIA News 06.02.24
Recording Now Available: EJP RD-EFPIA Joint Advanced Webinar on Real-World Data, Machine Learning, and...
...
Read Article -
EFPIA News 27.10.23
Stefan Oelrich's interview at the POLITICO Health Care Summit
Watch the recording.
Read Article -
EFPIA News 15.10.23
EFPIA Japan Day 2023
With a delegation from EFPIA in Brussels, EFPIA Japan recently held “EFPIA Day” in Tokyo
Read Article -
EFPIA News 13.07.23
Joint Position Paper on the Hospital Exemption Scheme for ATMPs
Our organisations are committed to engage with policymakers and interested stakeholders for an inclusive and solutions-driven approach on the HE in the...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 24.07.24
EFPIA position on EHDS
The EHDS will require the public and private sectors to work together in new and innovative ways. We look forward to working with the EU institutions and...
Read Article -
Statements & press releases 18.07.24
EFPIA Response to the publication of Political Guidelines for the Next European Commission 2024-2029
The dedicated life sciences strategy is an important part of the wider drive to boost European competitiveness over the next five years.
Read Article -
Statements & press releases 04.07.24
Joint Statement for an Ambitious FP10
Investing in Europe’s Future Competitiveness through Collaborative Research, Development, and Innovation
Read Article -
Statements & press releases 28.06.24
Strategic Agenda 2024-2029: an opportunity to close the gap with other regions of the world
As we begin a new EU mandate, the focus on competitiveness of the Strategic Agenda gives us an opportunity to restore Europe’s leadership in life sciences....
Read Article -
Statements & press releases 24.06.24
European pharmaceutical industry calls for Competitiveness Strategy and dedicated Office for European...
"Regaining Europe’s position as a world-leader in medical science requires strategic and dedicated focus at EU level" said Nathalie Moll.
Read Article -
Statements & press releases 10.06.24
Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement ...
We are leading the transition towards the decarbonisation in the pharmaceutical sector by setting ambitious science-based targets, investing in renewable...
Read Article -
Statements & press releases 05.06.24
Keep health front and centre in the EU elections and beyond – a call from the Patient Think Tank
The Patient Think Tank (PTT) is a forum for dialogue between the European research-based pharmaceutical industry and patient organisations, created and...
Read Article -
Statements & press releases 21.05.24
Pharmaceutical trade associations welcome latest announcement of largest number of regulatory agencies...
The WLA framework is crucial for regulatory convergence and harmonisation.
Read Article -
Statements & press releases 13.05.24
Joint business statement on the EU Proposal on Compulsory Licensing
We believe that, in its current form, this initiative will undermine innovation and competitiveness of European companies, ultimately impeding Europe's...
Read Article -
Statements & press releases 25.04.24
Critical Medicines Alliance: A positive collaboration to enhance medicines supply chain security and...
EFPIA will work within the Alliance to help build resilience through a number of recommendations
Read Article -
Statements & press releases 22.04.24
EFPIA Statement on the use of AI in the medicinal product lifecycle in the context of the AI Act
It is critical that the regulatory frameworks governing the use of AI in research, development and manufacture must be fit-for-purpose, risk-based, non-duplicative,...
Read Article -
Statements & press releases 19.04.24
EFPIA swings behind Council’s call for a European Competitiveness Deal
Time to close the gap
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 24.07.24
Data Sharing Playbook can unlock health partnerships
Health research collaborations mean sharing data – we can deliver faster if we identify and remove obstacles early, write IHI's Niklas Blomberg and EFPIA's...
Read Article -
Blog articles 04.07.24
Cardiovascular health: urgent action needed on EU’s #1 killer
Innovation and competitiveness must be at the heart of Council Conclusions on cardiovascular health
Read Article -
Blog articles 05.06.24
Incentives for the development of novel antimicrobials in the revision of the EU general pharmaceutical...
Antimicrobial resistance (AMR) is one of the most urgent global health threats of our time. The statistics are stark and alarming: in Europe alone, AMR...
Read Article -
Blog articles 28.05.24
New data demonstrates the value of regulatory data protection (RDP), and its impact on European competitiveness...
EFPIA believes EU leaders’ focus on competitiveness is positive but more joined-up thinking is urgently needed to achieve open strategic autonomy
Read Article -
Blog articles 20.05.24
Lab of the future: when science and technology meet to deliver medicines faster in Europe (Guest blog)...
As science evolves, if you're just keeping up, you're already behind the curve.
Read Article -
Blog articles 16.05.24
Advancing Clinical Trials for European Patients (Guest blog)
Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for clinical research.
Read Article -
Blog articles 15.05.24
Patient involvement in HTA (Guest blog)
Health Technology Assessments: What can we learn from experiences across Europe?
Read Article -
Blog articles 06.05.24
More than half of the direct expenditure on diabetes is associated with complications (Guest blog)
In the 2019-2022 period the average annual expenditure on diabetes amounted to 174 million euros.
Read Article -
Blog articles 26.03.24
Innovative Health Initiative: improving health, improving healthcare
From managing obesity to supporting healthier pregnancy, IHI is advancing people’s health and making health systems more efficient
Read Article -
Blog articles 12.03.24
Reintegrating cancer patients into professional and social life (Guest blog)
People with certain cancers are living longer, fuller lives. We must come together to support their return to work
Read Article -
Blog articles 12.03.24
Healthcare innovation moves fast – so should the European regulatory system (Guest blog)
What will the innovations of tomorrow look like and how can they be regulated effectively without delaying access?
Read Article -
Blog articles 06.03.24
How to Unlock the Power of Drug Repurposing? EFPIA perspective
We propose principles to guide policies and legislations that will ensure safety and efficacy of repurposed drugs.
Read Article